Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
The best research stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
We round up a selection of stocks in or related to the medical industry, weighting the list more heavily towards popular mid- and large-cap US stocks.
*Signup bonus information updated weekly.
Biocept, Inc. , a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms.
Biocept stock opened the day at $0.59 after a previous close of $0.55. The latest price was $0.55 (25-minute delay). Biocept is listed on the NASDAQ, has a trailing 12-month revenue of around USD50.1 million and employs 177 staff.
OPKO Health, Inc. , a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services.
Opko Health stock opened the day at $1.43 after a previous close of $1.38. The latest price was $1.44 (25-minute delay). Opko Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$1.2 billion and employs 5,767 staff.
Natera, Inc. , a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle.
Natera stock opened the day at $117.90 after a previous close of $117.29. The latest price was $120.94 (25-minute delay). Natera is listed on the NASDAQ, has a trailing 12-month revenue of around USD$776 million and employs 2,670 staff.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
Danaher Corporation stock opened the day at $269.00 after a previous close of $270.69. The latest price was $270.68 (25-minute delay). Danaher Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$31.5 billion and employs 81,000 staff.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments.
IDEXX Laboratories stock opened the day at $488.21 after a previous close of $483.20. The latest price was $504.22 (25-minute delay). IDEXX Laboratories is listed on the NASDAQ, has a trailing 12-month revenue of around USD$3.3 billion and employs 10,000 staff.
Co-Diagnostics, Inc. , a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications.
Co-Diagnostics stock opened the day at $3.16 after a previous close of $3.15. The latest price was $3.15 (25-minute delay). Co-Diagnostics is listed on the NASDAQ, has a trailing 12-month revenue of around USD$53.2 million and employs 101 staff.
DexCom, Inc. , a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.
DexCom stock opened the day at $109.17 after a previous close of $107.71. The latest price was $108.03 (25-minute delay). DexCom is listed on the NASDAQ, has a trailing 12-month revenue of around USD$2.8 billion and employs 6,300 staff.
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Laboratory Corporation of America stock opened the day at $249.09 after a previous close of $250.14. The latest price was $254.94 (25-minute delay). Laboratory Corporation of America is listed on the NYSE, has a trailing 12-month revenue of around USD$15.3 billion and employs 75,000 staff.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Agilent Technologies stock opened the day at $156.66 after a previous close of $155.48. The latest price was $155.50 (25-minute delay). Agilent Technologies is listed on the NYSE, has a trailing 12-month revenue of around USD$6.8 billion and employs 18,100 staff.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
Illumina stock opened the day at $218.88 after a previous close of $216.52. The latest price was $224.94 (25-minute delay). Illumina is listed on the NASDAQ, has a trailing 12-month revenue of around USD$4.7 billion and employs 9,800 staff.
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Thermo Fisher Scientific stock opened the day at $589.51 after a previous close of $587.36. The latest price was $588.32 (25-minute delay). Thermo Fisher Scientific is listed on the NYSE, has a trailing 12-month revenue of around USD$44.2 billion and employs 130,000 staff.
Sign up with an online broker or platform to invest in one or more of these research stocks.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.